Who we are

We focus on Technology Transfer with the goal to tap research potentials of most academic and research institutions in Italy, providing support for translating breakthrough discoveries into products and therapies for patients.

What we do

We build close ties with universities, research centers, technology transfer offices, biotechnology companies and patient foundations to access promising projects in their early discovery phase.

The selection process involves the evaluation of scientific ideas, protocols, drug candidates both from a scientific and marketing perspective. We perform feasibility assessment and de-risking activities within intellectual property positions, scientific validations, competition landscape analyses, regulatory activities and clinical trials to translate these projects into viable assets. We invest in a pre-seed and seed fashion to bridge the gap between basic research and industrial drug development with industrial discipline.

Our focus

We are focused on the Italian research and academic environment with a strong bias towards scientific projects with a clear therapeutic claim, persuasive in vivo data, a solid or solid-to-be intellectual property position, a committed team with a strong track record and a partnership attitude.

Our portfolio is focused on Oncology, Immunology, Rare Diseases, Infectious Diseases, Cardiovascular Diseases and CNS Diseases, with an open-mind to other areas with great value and potential.

We offer a comprehensive set of competences to manage multiple tasks required in the development process either in-house and through collaborators.


Where we act

We act in Italy for the scouting and fostering of the value flow and in Italy and globally for partnering, licensing, co-development and commercial agreements.